Faculty profile

Vikas Gupta

Back to faculty

ProfessorDepartment of MedicineUniversity of Toronto

Vikas Gupta

Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
38 publications in the last five years, latest in 2026.
Senior (last) author on 6 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

119

Publications

4,240

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.
Haematologica · 2026
A stem and progenitor cell–derived gene expression signature is prognostic for survival in myelofibrosis
Blood · 2026 · senior author
What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?
Clinical lymphoma, myeloma & leukemia · 2026

All 119 publications

Latest funding

Discovery of sex-dimorphic leukemia-protective programs embedded in human hematopoietic stem cells
CIHR · 2025 · Co-investigator
$1,591,200
Low-dose direct oral anticoagulant compared to aspirin for the thromboprophylaxis of patients with JAK2-positive myeloproliferative neoplasms
CIHR · 2024 · Co-investigator
$1,350,226
Discovery of epigenetic determinants regulating stemness to target the eradication of human pre-leukemic and leukemic stem cells
CIHR · 2024 · Co-investigator
$1,419,942

All 4 grants and awards

119 publications.

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.

Murphy T, Zhang B, Zhang T, King I, Capo-Chichi J-M, Gupta V, Maze D, McNamara CJ, Minden MD, Schimmer AD

Haematologica20266 citationsOpen Access

DOI: 10.3324/haematol.2025.287777

A stem and progenitor cell–derived gene expression signature is prognostic for survival in myelofibrosis

Jessie J.F. Medeiros, Andy G.X. Zeng, Suraj Bansal, H. Kim, Michelle Chan Seng Yue, Tristan Woo, Jessica L. McLeod, Sagar P. Kothari, Andrea Arruda, Hubert Tsui, Jaime O. Claudio, Dawn C. Maze, Hassan Abdulmaoula Sibai, M. D. Minden, James A. Kennedy, Christopher A. Famulare, Raajit K. Rampal, Jean C.Y. Wang, John Edgar Dick, V. Gupta

Blood20264 citationsSenior authorOpen Access

DOI: 10.1182/blood.2025030094 PMID: 41481381

What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?

Rajendra A, Smith E, Atenafu EG, Bankar A, Chan S, Davidson M, Gupta V, Minden MD, Perusini MA, Richard-Carpentier G, Schimmer A, Schuh AC, Sibai H, Yee K, Maze D

Clinical lymphoma, myeloma & leukemia2026

DOI: 10.1016/j.clml.2025.10.016 PMID: 41238480

Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias

Bhella S, Agbayani G, Hueniken K, Vijenthira A, Wilkin AM, Sebag M, Wang P, Hicks LK, Hay AE, Hosseini-Moghaddam SM

Blood advances2026Open Access

DOI: 10.1182/bloodadvances.2025018117

Extramedullary AML: Clinical and Molecular Features.

Morgenstern Y, Andrews C, Atenafu EG, Chan S, Gupta V, Minden MD, Maze D, Schimmer A, Schuh A, Yee K, Sibai H

Cancers2026Open Access

DOI: 10.3390/cancers18091362 PMID: 42122157

Identifying Risk Factors and Outcome for CNS Involvement in AML.

Seki JT, Daher-Reyes GS, Atenafu EG, Sibai J, Bankar A, Young T, Chan S, Yee K, Gupta V, Minden MD, Maze D, Schuh A, Schimmer A, Sibai H

Clinical lymphoma, myeloma & leukemia20253 citations

DOI: 10.1016/j.clml.2025.06.010 PMID: 40744760

Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis.

Rajendra A, Smith E, Perusini MA, Tang K, Atenafu EG, Bankar A, Chan S, Davidson MB, Gupta V, Maze D, Minden MD, Richard-Carpentier G, Schimmer AD, Schuh AC, Yee K, Sibai H

Blood cancer journal20251 citationsOpen Access

DOI: 10.1038/s41408-025-01353-2 PMID: 40854875

Real‐world experience with CPX ‐351 for secondary acute myeloid leukaemia: Comparison with FLAG ‐ IDA in a propensity score matching analysis

María Agustina Perusini, Ana Flavia Patiño, Claire Andrews, Sarit E. Assouline, Joseph M. Brandwein, Signy Chow, Gizelle Popradi, David Sanford, Mary Lynn Savoie, Lalit Saini, Bambace Nadia, Dina Khalaf, Andre C. Schuh, Karen W L Yee, Vikas K Gupta, Dawn C. Maze, Steven M. Chan, Aaron David Schimmer, Waleed Sabry, Hassan Abdulmaoula Sibai

British Journal of Haematology20251 citationsOpen Access

DOI: 10.1111/bjh.70275 PMID: 41344892

Longitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor-Naive or -Experienced Myelofibrosis Treated With Momelotinib.

Harrison CN, Mesa R, Talpaz M, Gupta V, Gerds AT, Perkins A, Goh YT, Fox ML, McLornan D, Palmer J, Foltz L, Vannucchi A, Koschmieder S, Passamonti F, Lee SE, Ellis C, Strouse B, Gonzalez Carreras FJ, Oh ST

Clinical lymphoma, myeloma & leukemia2025

DOI: 10.1016/j.clml.2024.10.001 PMID: 39516087

Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study

England JT, Szuber N, Sirhan S, Dunne T, Cerquozzi S, Hill M, Villeneuve PJA, Ho JM, Sadikovic B, Bhai P

Leukemia202416 citations

DOI: 10.1038/s41375-024-02155-4

Discovery of sex-dimorphic leukemia-protective programs embedded in human hematopoietic stem cells

Co-investigatorCIHR2025Project Grant

Principal investigators: Dick, John E; Kaufmann, Kerstin B

Keywords: Acute Myeloid Leukemia Biology,; Early Leukemogenesis; Human Hematopoietic Stem Cells; Human Leukemia Stem Cell Biology; Myeloproliferative Neoplasm Biology; Preleukemia; Sccut&Tag; Sex Dimorphisms; Single Cell Atac/Rna-Sequencing; Target-Seq,

$1,591,200

Low-dose direct oral anticoagulant compared to aspirin for the thromboprophylaxis of patients with JAK2-positive myeloproliferative neoplasms

Co-investigatorCIHR2024Project Grant

Principal investigators: Kimpton, Miriam; Delluc, Aurelien

Keywords: Cancer; Cardiovascular Outcomes; Randomized Controlled Trial; Thrombosis

$1,350,226

Discovery of epigenetic determinants regulating stemness to target the eradication of human pre-leukemic and leukemic stem cells

Co-investigatorCIHR2024Project Grant

Principal investigators: Dick, John E; Lupien, Mathieu

Keywords: Aml Biology; Crispr-Editing Of Human Hsc; Epigenetics; Human Hematopoietic Stem Cells; Human Leukemia Stem Cells; Non-Coding Regulatory Elements; Pre-Leukemic Human Hsc; Single Cell Atac/Rna-Sequencing; Single Cell Multiomics; Xenografting

$1,419,942

Early discontinuation of antibiotics for unexplained febrile neutropenia: a pilot randomized controlled trial- EASE ANTIBIOTICS pilot trial

Co-investigatorCIHR2023Project Grant

Principal investigators: Husain, Shahid; Belga, Sara; Daneman, Nick; Dufresne, Simon F; Haider, Shariq; Kabbani, Dima; Pérez-Cortés Villalobos, Armelle; Shalhoub, Sarah; Stern, Anat

Keywords: Acute Leukemia; Allogeneic Hematopoietic Stem Cell Transplant; Antibiotic Stewardship; Febrile Neutropenia

$512,551

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Vikas Gupta

Research

Latest papers

Latest funding

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.

A stem and progenitor cell–derived gene expression signature is prognostic for survival in myelofibrosis

What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?

Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias

Extramedullary AML: Clinical and Molecular Features.

Identifying Risk Factors and Outcome for CNS Involvement in AML.

Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis.

Real‐world experience with CPX ‐351 for secondary acute myeloid leukaemia: Comparison with FLAG ‐ IDA in a propensity score matching analysis

Longitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor-Naive or -Experienced Myelofibrosis Treated With Momelotinib.

Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study

Discovery of sex-dimorphic leukemia-protective programs embedded in human hematopoietic stem cells

Low-dose direct oral anticoagulant compared to aspirin for the thromboprophylaxis of patients with JAK2-positive myeloproliferative neoplasms

Discovery of epigenetic determinants regulating stemness to target the eradication of human pre-leukemic and leukemic stem cells

Early discontinuation of antibiotics for unexplained febrile neutropenia: a pilot randomized controlled trial- EASE ANTIBIOTICS pilot trial

Frequent collaborators

Mark Minden

Aaron Schimmer

Dawn Maze

John Kuruvilla

Hassan Sibai

Auro Viswabandya

Karen Yee

Steven Chan

Aniket Bankar

Dennis Kim

Andre Schuh

Brian Leber

Wilson Lam

Tony Panzarella

Jonas Mattsson

Lambert Busque

Rajat Kumar

Guillaume Richard-Carpentier

Christopher Bredeson

Christopher Hillis

Wei Xu

John Dick

Justyna Bartoszko

Maria Perusini

Jean Wang

Stephanie Lee

Ann Malinowski

Natasha Szuber

Waleed Sabry

Coleman Rotstein

Prakesh Shah

Anca Prica

Rouslan Kotchetkov